New

Liposome Assisted Drug Delivery Market

2021

Liposome Assisted Drug Delivery Market Forecast to 2028 - COVID-19 Impact and Global Analysis by Product (Liposomal Doxorubicin, Liposomal Amphoteracin B, Liposomal Paclitaxel, Others); Application (Fungal Infection Therapy, Cancer and Tumor Therapy, Others)

| Report Code: TIPRE00013462 | No. of Pages: 150 | Category: Medical Device | Status: Upcoming

Market Insights

Liposome Assisted Drug Delivery Market 2028 By Product, Application | The Insight Partners

Covid
Assesing the covid-19 impact?
Get the Latest COVID-19 Analysis on this market
Request Now
Happy to join you in your fight against the COVID-19 economic pandemic!
MARKET INTRODUCTION

Liposomes are a novel drug delivery system (NDDS), formed by spontaneous dispersion of phospholipids in water. Liposomes are aqueous bilayer vesicular structures of phospholipids. They are microscopic vesicles in which an aqueous volume is completely surrounded by a membrane composed of lipid bilayers. This novel drug delivery system aims to deliver the drug at targeted site and at a rate directed by the requirement of the body over the period of treatment. Some of the drugs are formulated as liposomes in order to improve their therapeutic index such as doxorubicin, paclitaxel, amphotericin and others.

MARKET DYNAMICS

Major factor driving the growth of the global Liposome Assisted Drug Delivery market is the increased research in liposome technology and its role in modulating drug delivery systems in human body and advantages offered by liposomal drug delivery such as reduced toxicities and enhanced efficacy. Growing interests across the healthcare continuum across the world has resulted into increasing research and development activities in an ever-evolving Liposome Assisted Drug Delivery landscape and technological advancements in novel drug delivery systems. Furthermore, growing adoption of Liposome Assisted Drug Delivery in order to particular diseased cells such as malignant cells will continue to propel the overall market growth. However, High costs of production for Liposome Assisted Drug Delivery and Short half-life Low solubility in body of liposome are some of the factors restraining the market growth.

MARKET SCOPE

The Liposome Assisted Drug Delivery market analysis to 2028 is a specialized and in-depth study of the healthcare industry with a special focus on the global market trend analysis. The report aims to provide an overview of Liposome Assisted Drug Delivery market with detailed market segmentation by product and applications. The Liposome Assisted Drug Delivery market is expected to witness high growth during the forecast period. The report provides key statistics on the market status of the leading players in Liposome Assisted Drug Delivery market and offers key trends and opportunities in the market.

MARKET SEGMENTATION

The Liposome Assisted Drug Delivery market is segmented on the basis of Product and Application. Based on Product, the market is segmented as Liposomal Doxorubicin, Liposomal Amphotericin B, Liposomal Paclitaxel, Others. On the basis of application, the market is segmented as Fungal Infection Therapy, Cancer & Tumor Therapy, Others.

REGIONAL FRAMEWORK

The report provides a detailed overview of the industry including both qualitative and quantitative information. It provides overview and forecast of the Liposome Assisted Drug Delivery market based on various segments. It also provides market size and forecast estimates from year 2020 to 2028 with respect to five major regions, namely; North America, Europe, Asia-Pacific (APAC), Middle East and Africa (MEA) and South & Central America. The Liposome Assisted Drug Delivery market by each region is later sub-segmented by respective countries and segments. The report covers analysis and forecast of 18 countries globally along with current trend and opportunities prevailing in the region.

The report analyzes factors affecting Liposome Assisted Drug Delivery market from both demand and supply side and further evaluates market dynamics affecting the market during forecast period i.e., drivers, restraints, opportunities, and future trend. The report also provides exhaustive PEST analysis for all five regions namely; North America, Europe, APAC, MEA and South & Central America after evaluating political, economic, social and technological factors effecting the Liposome Assisted Drug Delivery market in these regions.



Get more information on this report :

MARKET PLAYERS


The report covers key developments in the Liposome Assisted Drug Delivery market as organic and inorganic growth strategies. Various companies are focusing on organic growth strategies such as product launches, product approvals and others such as patents and events. Inorganic growth strategies witnessed in the market were acquisitions, and partnership & collaborations. These activities have paved way for expansion of business and customer base of market players. The market players from Liposome Assisted Drug Delivery market are anticipated to have lucrative growth opportunities in the future with the rising demand for Liposome Assisted Drug Delivery in the global market. Below mentioned is the list of few companies engaged in the Liposome Assisted Drug Delivery market.

The report also includes the profiles of key players in Liposome Assisted Drug Delivery market along with their SWOT analysis and market strategies. In addition, the report focuses on leading industry players with information such as company profiles, components and services offered, financial information of last 3 years, key development in past five years.

  •  Gilead Sciences
  •  Novartis
  •  Pacira
  •  Johnson & Johnson
  •  Luye Pharma
  •  Sun Pharmaceutical
  •  Fudan-Zhangjiang
  •  Sigma-Tau Group
  •  Teva Pharmaceutical
  •  Ipsen (Onivyde)

The Insight Partner's dedicated research and analysis team consists of experienced professionals with advanced statistical expertise and offers various customization options in the existing study.


Get more information on this report :

TABLE OF CONTENTS

1. INTRODUCTION
1.1. SCOPE OF THE STUDY
1.2. THE INSIGHT PARTNERS RESEARCH REPORT GUIDANCE
1.3. MARKET SEGMENTATION
1.3.1 Liposome Assisted Drug Delivery Market - By Product
1.3.2 Liposome Assisted Drug Delivery Market - By Application
1.3.3 Liposome Assisted Drug Delivery Market - By Region
1.3.3.1 By Country
2. KEY TAKEAWAYS
3. RESEARCH METHODOLOGY
4. LIPOSOME ASSISTED DRUG DELIVERY MARKET LANDSCAPE
4.1. OVERVIEW
4.2. PEST ANALYSIS
4.2.1 North America - Pest Analysis
4.2.2 Europe - Pest Analysis
4.2.3 Asia-Pacific - Pest Analysis
4.2.4 Middle East and Africa - Pest Analysis
4.2.5 South and Central America - Pest Analysis
4.3. EXPERT OPINIONS
5. LIPOSOME ASSISTED DRUG DELIVERY MARKET - KEY MARKET DYNAMICS
5.1. KEY MARKET DRIVERS
5.2. KEY MARKET RESTRAINTS
5.3. KEY MARKET OPPORTUNITIES
5.4. FUTURE TRENDS
5.5. IMPACT ANALYSIS OF DRIVERS AND RESTRAINTS
6. LIPOSOME ASSISTED DRUG DELIVERY MARKET - GLOBAL MARKET ANALYSIS
6.1. LIPOSOME ASSISTED DRUG DELIVERY - GLOBAL MARKET OVERVIEW
6.2. LIPOSOME ASSISTED DRUG DELIVERY - GLOBAL MARKET AND FORECAST TO 2028
6.3. MARKET POSITIONING/MARKET SHARE
7. LIPOSOME ASSISTED DRUG DELIVERY MARKET - REVENUE AND FORECASTS TO 2028 - PRODUCT
7.1. OVERVIEW
7.2. PRODUCT MARKET FORECASTS AND ANALYSIS
7.3. LIPOSOMAL DOXORUBICIN
7.3.1. Overview
7.3.2. Liposomal Doxorubicin Market Forecast and Analysis
7.4. LIPOSOMAL AMPHOTERACIN B
7.4.1. Overview
7.4.2. Liposomal Amphoteracin B Market Forecast and Analysis
7.5. LIPOSOMAL PACLITAXEL
7.5.1. Overview
7.5.2. Liposomal Paclitaxel Market Forecast and Analysis
7.6. OTHERS
7.6.1. Overview
7.6.2. Others Market Forecast and Analysis
8. LIPOSOME ASSISTED DRUG DELIVERY MARKET - REVENUE AND FORECASTS TO 2028 - APPLICATION
8.1. OVERVIEW
8.2. APPLICATION MARKET FORECASTS AND ANALYSIS
8.3. FUNGAL INFECTION THERAPY
8.3.1. Overview
8.3.2. Fungal Infection Therapy Market Forecast and Analysis
8.4. CANCER AND TUMOR THERAPY
8.4.1. Overview
8.4.2. Cancer and Tumor Therapy Market Forecast and Analysis
8.5. OTHERS
8.5.1. Overview
8.5.2. Others Market Forecast and Analysis
9. LIPOSOME ASSISTED DRUG DELIVERY MARKET REVENUE AND FORECASTS TO 2028 - GEOGRAPHICAL ANALYSIS
9.1. NORTH AMERICA
9.1.1 North America Liposome Assisted Drug Delivery Market Overview
9.1.2 North America Liposome Assisted Drug Delivery Market Forecasts and Analysis
9.1.3 North America Liposome Assisted Drug Delivery Market Forecasts and Analysis - By Product
9.1.4 North America Liposome Assisted Drug Delivery Market Forecasts and Analysis - By Application
9.1.5 North America Liposome Assisted Drug Delivery Market Forecasts and Analysis - By Countries
9.1.5.1 United States Liposome Assisted Drug Delivery Market
9.1.5.1.1 United States Liposome Assisted Drug Delivery Market by Product
9.1.5.1.2 United States Liposome Assisted Drug Delivery Market by Application
9.1.5.2 Canada Liposome Assisted Drug Delivery Market
9.1.5.2.1 Canada Liposome Assisted Drug Delivery Market by Product
9.1.5.2.2 Canada Liposome Assisted Drug Delivery Market by Application
9.1.5.3 Mexico Liposome Assisted Drug Delivery Market
9.1.5.3.1 Mexico Liposome Assisted Drug Delivery Market by Product
9.1.5.3.2 Mexico Liposome Assisted Drug Delivery Market by Application
9.2. EUROPE
9.2.1 Europe Liposome Assisted Drug Delivery Market Overview
9.2.2 Europe Liposome Assisted Drug Delivery Market Forecasts and Analysis
9.2.3 Europe Liposome Assisted Drug Delivery Market Forecasts and Analysis - By Product
9.2.4 Europe Liposome Assisted Drug Delivery Market Forecasts and Analysis - By Application
9.2.5 Europe Liposome Assisted Drug Delivery Market Forecasts and Analysis - By Countries
9.2.5.1 Germany Liposome Assisted Drug Delivery Market
9.2.5.1.1 Germany Liposome Assisted Drug Delivery Market by Product
9.2.5.1.2 Germany Liposome Assisted Drug Delivery Market by Application
9.2.5.2 France Liposome Assisted Drug Delivery Market
9.2.5.2.1 France Liposome Assisted Drug Delivery Market by Product
9.2.5.2.2 France Liposome Assisted Drug Delivery Market by Application
9.2.5.3 Italy Liposome Assisted Drug Delivery Market
9.2.5.3.1 Italy Liposome Assisted Drug Delivery Market by Product
9.2.5.3.2 Italy Liposome Assisted Drug Delivery Market by Application
9.2.5.4 Spain Liposome Assisted Drug Delivery Market
9.2.5.4.1 Spain Liposome Assisted Drug Delivery Market by Product
9.2.5.4.2 Spain Liposome Assisted Drug Delivery Market by Application
9.2.5.5 United Kingdom Liposome Assisted Drug Delivery Market
9.2.5.5.1 United Kingdom Liposome Assisted Drug Delivery Market by Product
9.2.5.5.2 United Kingdom Liposome Assisted Drug Delivery Market by Application
9.3. ASIA-PACIFIC
9.3.1 Asia-Pacific Liposome Assisted Drug Delivery Market Overview
9.3.2 Asia-Pacific Liposome Assisted Drug Delivery Market Forecasts and Analysis
9.3.3 Asia-Pacific Liposome Assisted Drug Delivery Market Forecasts and Analysis - By Product
9.3.4 Asia-Pacific Liposome Assisted Drug Delivery Market Forecasts and Analysis - By Application
9.3.5 Asia-Pacific Liposome Assisted Drug Delivery Market Forecasts and Analysis - By Countries
9.3.5.1 Australia Liposome Assisted Drug Delivery Market
9.3.5.1.1 Australia Liposome Assisted Drug Delivery Market by Product
9.3.5.1.2 Australia Liposome Assisted Drug Delivery Market by Application
9.3.5.2 China Liposome Assisted Drug Delivery Market
9.3.5.2.1 China Liposome Assisted Drug Delivery Market by Product
9.3.5.2.2 China Liposome Assisted Drug Delivery Market by Application
9.3.5.3 India Liposome Assisted Drug Delivery Market
9.3.5.3.1 India Liposome Assisted Drug Delivery Market by Product
9.3.5.3.2 India Liposome Assisted Drug Delivery Market by Application
9.3.5.4 Japan Liposome Assisted Drug Delivery Market
9.3.5.4.1 Japan Liposome Assisted Drug Delivery Market by Product
9.3.5.4.2 Japan Liposome Assisted Drug Delivery Market by Application
9.3.5.5 South Korea Liposome Assisted Drug Delivery Market
9.3.5.5.1 South Korea Liposome Assisted Drug Delivery Market by Product
9.3.5.5.2 South Korea Liposome Assisted Drug Delivery Market by Application
9.4. MIDDLE EAST AND AFRICA
9.4.1 Middle East and Africa Liposome Assisted Drug Delivery Market Overview
9.4.2 Middle East and Africa Liposome Assisted Drug Delivery Market Forecasts and Analysis
9.4.3 Middle East and Africa Liposome Assisted Drug Delivery Market Forecasts and Analysis - By Product
9.4.4 Middle East and Africa Liposome Assisted Drug Delivery Market Forecasts and Analysis - By Application
9.4.5 Middle East and Africa Liposome Assisted Drug Delivery Market Forecasts and Analysis - By Countries
9.4.5.1 South Africa Liposome Assisted Drug Delivery Market
9.4.5.1.1 South Africa Liposome Assisted Drug Delivery Market by Product
9.4.5.1.2 South Africa Liposome Assisted Drug Delivery Market by Application
9.4.5.2 Saudi Arabia Liposome Assisted Drug Delivery Market
9.4.5.2.1 Saudi Arabia Liposome Assisted Drug Delivery Market by Product
9.4.5.2.2 Saudi Arabia Liposome Assisted Drug Delivery Market by Application
9.4.5.3 U.A.E Liposome Assisted Drug Delivery Market
9.4.5.3.1 U.A.E Liposome Assisted Drug Delivery Market by Product
9.4.5.3.2 U.A.E Liposome Assisted Drug Delivery Market by Application
9.5. SOUTH AND CENTRAL AMERICA
9.5.1 South and Central America Liposome Assisted Drug Delivery Market Overview
9.5.2 South and Central America Liposome Assisted Drug Delivery Market Forecasts and Analysis
9.5.3 South and Central America Liposome Assisted Drug Delivery Market Forecasts and Analysis - By Product
9.5.4 South and Central America Liposome Assisted Drug Delivery Market Forecasts and Analysis - By Application
9.5.5 South and Central America Liposome Assisted Drug Delivery Market Forecasts and Analysis - By Countries
9.5.5.1 Brazil Liposome Assisted Drug Delivery Market
9.5.5.1.1 Brazil Liposome Assisted Drug Delivery Market by Product
9.5.5.1.2 Brazil Liposome Assisted Drug Delivery Market by Application
9.5.5.2 Argentina Liposome Assisted Drug Delivery Market
9.5.5.2.1 Argentina Liposome Assisted Drug Delivery Market by Product
9.5.5.2.2 Argentina Liposome Assisted Drug Delivery Market by Application
10. IMPACT OF COVID-19 PANDEMIC ON GLOBAL LIPOSOME ASSISTED DRUG DELIVERY MARKET
10.1 North America
10.2 Europe
10.3 Asia-Pacific
10.4 Rest of the World
11. INDUSTRY LANDSCAPE
11.1. MERGERS AND ACQUISITIONS
11.2. AGREEMENTS, COLLABORATIONS AND JOIN VENTURES
11.3. NEW PRODUCT LAUNCHES
11.4. EXPANSIONS AND OTHER STRATEGIC DEVELOPMENTS
12. LIPOSOME ASSISTED DRUG DELIVERY MARKET, KEY COMPANY PROFILES
12.1. GILEAD SCIENCES
12.1.1. Key Facts
12.1.2. Business Description
12.1.3. Products and Services
12.1.4. Financial Overview
12.1.5. SWOT Analysis
12.1.6. Key Developments
12.2. NOVARTIS
12.2.1. Key Facts
12.2.2. Business Description
12.2.3. Products and Services
12.2.4. Financial Overview
12.2.5. SWOT Analysis
12.2.6. Key Developments
12.3. PACIRA
12.3.1. Key Facts
12.3.2. Business Description
12.3.3. Products and Services
12.3.4. Financial Overview
12.3.5. SWOT Analysis
12.3.6. Key Developments
12.4. JOHNSON AND JOHNSON
12.4.1. Key Facts
12.4.2. Business Description
12.4.3. Products and Services
12.4.4. Financial Overview
12.4.5. SWOT Analysis
12.4.6. Key Developments
12.5. LUYE PHARMA
12.5.1. Key Facts
12.5.2. Business Description
12.5.3. Products and Services
12.5.4. Financial Overview
12.5.5. SWOT Analysis
12.5.6. Key Developments
12.6. SUN PHARMACEUTICAL
12.6.1. Key Facts
12.6.2. Business Description
12.6.3. Products and Services
12.6.4. Financial Overview
12.6.5. SWOT Analysis
12.6.6. Key Developments
12.7. FUDAN-ZHANGJIANG
12.7.1. Key Facts
12.7.2. Business Description
12.7.3. Products and Services
12.7.4. Financial Overview
12.7.5. SWOT Analysis
12.7.6. Key Developments
12.8. SIGMA-TAU GROUP
12.8.1. Key Facts
12.8.2. Business Description
12.8.3. Products and Services
12.8.4. Financial Overview
12.8.5. SWOT Analysis
12.8.6. Key Developments
12.9. TEVA PHARMACEUTICAL
12.9.1. Key Facts
12.9.2. Business Description
12.9.3. Products and Services
12.9.4. Financial Overview
12.9.5. SWOT Analysis
12.9.6. Key Developments
12.10. IPSEN (ONIVYDE)
12.10.1. Key Facts
12.10.2. Business Description
12.10.3. Products and Services
12.10.4. Financial Overview
12.10.5. SWOT Analysis
12.10.6. Key Developments
13. APPENDIX
13.1. ABOUT THE INSIGHT PARTNERS
13.2. GLOSSARY OF TERMS
The List of Companies

1. Gilead Sciences
2. Novartis
3. Pacira
4. Johnson & Johnson
5. Luye Pharma
6. Sun Pharmaceutical
7. Fudan-Zhangjiang
8. Sigma-Tau Group
9. Teva Pharmaceutical
10. Ipsen (Onivyde)
TIPRE00013462
Your data will never be shared with third parties, however, we may send you information from time to time about our products that may be of interest to you. By submitting your details, you agree to be contacted by us. You may contact us at any time to opt-out.

Pricing

Free

20%

customization on Pre-Booking
Request for Sample
Your data will never be shared with third parties, however, we may send you information from time to time about our products that may be of interest to you. By submitting your details, you agree to be contacted by us. You may contact us at any time to opt-out.